Smith Thornton Advisors LLC Pfizer Inc Transaction History

Smith Thornton Advisors LLC

  • $161 Billion
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025
SELL
$24.8 - $30.19 $79,037 - $96,215
-3,187 Reduced 28.88%
7,848 $208 Million
Q3 2024

Oct 31, 2024
SELL
$27.7 - $31.39 $2,354 - $2,668
-85 Reduced 0.76%
11,035 $319 Million
Q2 2024

Aug 15, 2024
BUY
$25.26 - $29.6 $280,891 - $329,152
11,120 New
11,120 $311 Million

Others Institutions Holding PFE

# of Institutions
3,371
Shares Held
3.61B
Call Options Held
102M
Put Options Held
130M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $136B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Smith Thornton Advisors LLC Portfolio

Follow Smith Thornton Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith Thornton Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smith Thornton Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email